❯ Cyera adds $400 million to Series G for enterprise agent security

What it sellsCyera helps enterprises locate sensitive data, inspect access rights and control what employees, software identities and AI agents can read or do. Because an agent can call tools, query databases and take actions, looking only at its prompts and responses misses much of the risk. Its Agent Guardian and endpoint products track those intervening steps.

How it got hereCyera began with enterprise data security: finding where sensitive information lives and determining which accounts can reach it. As enterprises connect AI agents to internal systems, the question expands from who can see data to which identity an agent uses, which tools it calls and what it ultimately does. This year Cyera introduced Agent Guardian and endpoint products and acquired Oasis Security, adding nonhuman-identity management to its data view.

The financingEnterprise data security company Cyera announced a $400 million Series G extension from Growth Equity at Goldman Sachs Alternatives. Evolution Equity led the round. Cyera says its valuation exceeds $12 billion; Crunchbase data puts cumulative funding at about $2.7 billion.

Industry impactCyera will invest in AI security products, the US federal market and international expansion. Separate discovery, identity and agent-monitoring tools can leave permission gaps for enterprise security teams; Cyera aims to connect those functions. Its advantage will depend on whether it can keep finding excessive access across complex customer systems and reduce it without interrupting legitimate work.

▪ SIGNALAgent security is moving from finding sensitive data to continuously matching data, identities and actual actions.

❯ Snorkel AI raises $350 million at a $3.5 billion valuation

Business shiftFounded by Stanford AI Lab researchers in 2019, Snorkel initially sold data-development software. It now increasingly sells finished datasets and reinforcement-learning environments to frontier labs. Domain experts design tasks, scenarios and grading rubrics while specialized models and agents help produce and check the material. Customers pay for training and evaluation outputs, rather than simply buying expert hours.

How it got hereFounded out of the Stanford AI Lab in 2019, Snorkel first sold software for developing training data. After launching data as a service in September 2025, it increasingly began delivering finished datasets and reinforcement-learning environments to model labs. Reuters says its previous $100 million financing in May 2025 valued it at $1.3 billion; demand following the shift helped lift its annualized revenue run-rate.

The financingReuters reported that Snorkel AI raised $350 million in Series E funding, co-led by Insight Partners and S32, at a $3.5 billion valuation. The valuation differs from the $3.2 billion in the supplied lead. Reuters quoted its CEO as saying annualized revenue run-rate exceeded $350 million; that is not completed full-year revenue.

Industry impactThe round will fund research and engineering hires, enterprise and government expansion, and third-party model evaluations. Buying expert-designed data for complex tasks can spare frontier labs from assembling every expert and quality-control process themselves. Suppliers increasingly compete on task design, consistent quality and delivery efficiency, not just the size of their labeling workforce. The reported annualized run-rate is not full-year realized revenue.

▪ SIGNALThe value in AI training data is shifting from labeling volume to expert-designed tasks and verifiable training value.

❯ Enveda raises $311 million to advance nature-derived drugs

Discovery approachEnveda searches natural compounds for possible drug candidates. It combines experimental data, chemical analysis and machine learning to prioritize molecules, then moves candidates through conventional preclinical and clinical development. AI can narrow the search, but trials must establish efficacy and safety.

Development pathEnveda starts with natural compounds, using experiments and algorithms to prioritize possible drug molecules before moving candidates through preclinical and clinical development. It has raised more than $845 million in total, reflecting the sustained capital needed both to build the platform and advance drugs. Natural products provide a differentiated search space, but each candidate must still prove developable.

The financingColorado-based drug developer Enveda announced a $311 million Series E led by Catalio Capital Management. It says it has raised more than $845 million since inception, and a Catalio representative has joined its board.

Industry impactTechCrunch reported a valuation of about $2 billion; the new money will help move more programs into trials. Pharmaceutical partners need repeatable evidence that the platform can find candidates with efficacy, safety and manufacturability, not simply a large molecule count. For investors, clinical progress will increasingly matter more than platform scale. AI does not eliminate the possibility of trial failure.

▪ SIGNALLarge AI-drug rounds ultimately have to pay off in clinical progress and trial results, not discovery throughput alone.

❯ Rightway raises $155 million to expand pharmacy benefits and AI

The customer problemRightway serves employers by combining pharmacist guidance, drug selection and pricing management to help workers obtain appropriate medications while controlling company spending. It says 45 Fortune 500 companies are customers. Its contracts emphasize a cap on total pharmacy spend, net-cost pricing for certain expensive drugs and full rebate pass-through, positioning it differently from intermediaries that can benefit when drug prices rise.

Business historyRightway built its business by combining pharmacy-benefit management with pharmacist-led navigation. Employers pay to manage benefits, while employees get help choosing appropriate medication and understanding costs. The company says 45 Fortune 500 firms are clients and highlights total-spend guarantees, net-cost pricing for some expensive drugs and full rebate pass-through. It established employer and member relationships before adding AI to back-end workflows.

The financingRightway announced a $155 million Series E led by Francisco Partners, with existing investors Thrive Capital and Khosla Ventures participating. The pharmacy-benefit and care-navigation company will invest in growth, back-end AI and its pharmacy technology.

Industry impactRightway will expand pharmacy technology and AI capabilities. Traditional pharmacy supply-chain fees and rebates can obscure an employer’s true cost; a model that lowers total spending while preserving clinical support could pressure incumbents. The test is actual drug spending, members’ treatment outcomes and service experience, not the number of AI features launched.

▪ SIGNALAI in pharmacy benefits has to show up in measurable drug spending and accessible professional care.

❯ Rainmaker raises $100 million to expand cloud-seeding research

Technology and limitsRainmaker flies rugged drones into suitable clouds to release silver iodide, which can encourage cloud droplets or ice crystals to form precipitation. The process cannot create clouds from nothing. Measuring incremental rain or snow requires separating seeding effects from precipitation that would have occurred naturally; the company uses planned flight patterns and field measurements to assess its work.

Earlier workFounded in 2023, Rainmaker developed rugged drones that release silver iodide into suitable clouds. Fast Company says it had raised about $50.3 million before this round. The company now combines flight patterns with precipitation measurements to distinguish seeding effects from natural rainfall. It attributes about 145 million gallons of incremental freshwater to its work, including about 19 million gallons in an Alaska test; both are company-reported figures.

The financingFast Company reported that Rainmaker raised a $100 million Series B, with NOA, Upfront Ventures, DCVC, Lowercarbon Capital and Dream Ventures among the investors. The weather-modification company did not disclose its new valuation. It had previously raised about $50.3 million in venture capital.

Industry impactThe funding will support hires in meteorology, machine learning and aerosol chemistry, as well as outside validation. For water-stressed regions, reliable additional water at a workable cost could complement existing management tools. Seeding requires suitable weather and cannot create water from nothing. Buyers ultimately need independent measurements of incremental yield, unit cost and environmental effects rather than a single test result.

▪ SIGNALFunding enthusiasm for water technology is ahead of scaled evidence; independent measurement will determine whether customers can buy it.

❯ Numeral raises $100 million for AI-assisted tax compliance

What it automatesCompanies selling across states and countries must determine where tax obligations arise, register, calculate tax, file and remit. Numeral connects these processes and exemption-certificate management to billing and finance systems. It also supports VAT or GST compliance in more than 90 countries. A deterministic tax engine handles calculation, AI and automation assist with repetitive work, and specialists handle more complex questions.

Growth pathFounded in 2023, Numeral raised a $35 million Series B in September 2025. It expanded from sales-tax calculation and filing into obligation monitoring, registration, remittance and exemption-certificate management, connecting these functions to billing and finance systems. It also supports VAT or GST compliance in more than 90 countries. Numeral reports 327% year-over-year transaction-volume growth and expects its engine to process over 80 million transactions.

The financingNumeral announced a $100 million Series C led by Insight Partners, with Salesforce Ventures, Geodesic and others participating. The tax-software company raised a $35 million Series B in September 2025 and says total funding now stands at $157 million.

Industry impactThe new capital will fund products, hiring and expansion into software, manufacturing, distribution and wholesale. Tax rules change as companies enter new markets and sell new products, so processes need constant updating. Numeral could become everyday finance infrastructure if deterministic calculations, AI-assisted operations and human specialists handle routine work and exceptions reliably. Customers will judge accuracy, timely filing and accountability when something goes wrong.

▪ SIGNALCompliance AI becomes enterprise infrastructure when it is paired with rules, human escalation and accountable outcomes.

❯ Micro1 reportedly raises over $100 million at a $4 billion valuation

What it sellsMicro1 organizes expert-generated data, realistic training environments and model evaluations for major AI labs. Its website describes expert human data, reinforcement-learning environments and evaluations for agentic behavior. The work exposes models to coding, professional judgment and multistep tasks beyond generic web text.

Development pathMicro1’s work for model labs spans expert human data, realistic reinforcement-learning environments and agent evaluations. Training capable models requires more than additional samples: people must design tasks, supply professional answers and judge whether a model completed multistep work. Its website describes those product lines, but the supplied report does not establish detailed terms or a full investor list for the new financing.

The reportForbes reported on September 22, citing people familiar with the deal, that San Francisco-based Micro1 raised more than $100 million at a valuation of about $4 billion. The supplied report did not establish a round designation or full investor roster, so the transaction is described as reported rather than company-confirmed.

Industry impactThe large reported round alongside Snorkel AI’s financing indicates continued capital interest in difficult training data and environments. External vendors can help labs iterate faster if they deliver dependable expert work and testing scenarios. Micro1 must expand expert supply without sacrificing quality. Forbes’ reported $4 billion valuation is a transaction price, not a substitute for verified revenue or delivery performance.

▪ SIGNALAI-data advantage increasingly rests on reliably organizing experts and realistic tasks, not a single financing valuation.

❯ Baselayer raises $35 million for AI-agent identity verification

Existing businessBaselayer already helps financial institutions verify businesses and assess fraud risk: before onboarding or a transaction, a bank needs to know that the applicant exists and its information is credible. Baselayer is extending that logic to agents acting for people or companies, aiming to identify the party behind an agent and the bounds of its authorization.

Business historyBaselayer already helped financial institutions verify business identities and assess fraud. Before opening an account or approving a transaction, a bank needs to know that a company is real and its information credible. As AI agents start acting for users, verification must also cover who stands behind the agent and what authority it actually has. Baselayer extended its existing risk-control experience into agent identity infrastructure, launching the new product alongside the round.

The financingAccording to Crunchbase News and a company release, fintech company Baselayer raised a $35 million Series A led by M13, with Torch Capital, Picus Ventures, Afore Capital and others participating. It also introduced identity infrastructure for AI agents.

Industry impactThe company is targeting agent builders, card networks and financial institutions. If agents initiate payments or other consequential actions, confirming software origin alone does not show whether an action was authorized; the chain also needs to verify delegation and permission scope. Baselayer could supply that trust layer, but adoption and interoperability will determine whether it becomes a common standard.

▪ SIGNALWhen agents transact for people and companies, identity checks may extend from onboarding to each machine-initiated action.

OUTLOOK

What to watchThese eight deals do not describe one uniform AI market. Cyera, Baselayer and Numeral address enterprise demand for permissions, identity and compliance outcomes; Snorkel AI and Micro1 supply training and evaluation material to model developers; Enveda and Rainmaker must turn discovery and engineering methods into clinical or field results. The seven financings with exact disclosed amounts total $1.451 billion. Micro1’s reported “more than $100 million” is excluded from that exact sum. The next tests are whether security tools enter real agent workflows, data vendors repeatedly deliver difficult tasks, and drug and cloud-seeding projects produce independently verifiable results.